Last reviewed · How we verify

NCT03817372: EPIC

Electrode Positions in Cardioverting Atrial Fibrillation

Completed NA Last updated 8 October 2020
What this trial tests

NA trial testing Anterior-posterior electrode position in Atrial Fibrillation in 468 participants. Completed in 2 October 2020.

Timeline
19 February 2019
Primary endpoint
2 October 2020
2 October 2020

Quick facts

Lead sponsorUniversity of Aarhus
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment468
Start date19 February 2019
Primary completion2 October 2020
Estimated completion2 October 2020
Sites3 locations across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University of Aarhus

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Atrial fibrillation is the most common heart rhythm disorder, and the incidence is rapidly increasing. Cardioversion using an electrical shock (DC-cardioversion) is an important treatment to reduce symptoms and improve patient's quality-of-life. The treatment is performed by applying gel electrodes to the chest. Cardioversion is not always successful, and it is unknown which electrode-position provides the optimal efficacy. This study aims to compare two electrode positions, which are in clinical use: Anterior-posterior (left front and left back) versus anterior-lateral (right front and left side of the chest).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
    Schmidt AS, Lauridsen KG, Møller DS, Christensen PD, et al · · 2021 · cited 27× · PMID 34814700 · DOI 10.1161/circulationaha.121.056301
  2. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K, Ahmad M, Carrington M, Ioannou A, et al · · 2024 · cited 6× · PMID 38828867 · DOI 10.1002/14651858.cd013255.pub2

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other University of Aarhus trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03817372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing